Clovamide and Its Derivatives-Bioactive Components of Theobroma cacao and Other Plants in the Context of Human Health.
Joanna Kolodziejczyk-CzepasPublished in: Foods (Basel, Switzerland) (2024)
Clovamide ( N -caffeoyl-L-3,4-dihydroxyphenylalanine, N -caffeoyldopamine, N -caffeoyl-L-DOPA) is a derivative of caffeic acid, belonging to phenolamides (hydroxycinnamic acid amides). Despite a growing interest in the biological activity of natural polyphenolic substances, studies on the properties of clovamide and related compounds, their significance as bioactive components of the diet, as well as their effects on human health are a relatively new research trend. On the other hand, in vitro and in vivo evidence indicates the considerable potential of these substances in the context of maintaining human health or using them as pharmacophores. The name "clovamide" directly derives from red clover ( Trifolium pratense L.), being the first identified source of this compound. In the human diet, clovamides are mainly present in chocolate and other cocoa-containing products. Furthermore, their occurrence in some medicinal plants has also been confirmed. The literature reports deal with the antioxidant, anti-inflammatory, neuroprotective, antiplatelet/antithrombotic and anticancer properties of clovamide-type compounds. This narrative review summarizes the available data on the biological activity of clovamides and their potential health-supporting properties, including prospects for the use of these compounds for therapeutic purposes.
Keyphrases
- human health
- risk assessment
- anti inflammatory
- climate change
- physical activity
- weight loss
- endothelial cells
- systematic review
- drinking water
- atrial fibrillation
- public health
- mental health
- emergency department
- electronic health record
- big data
- pluripotent stem cells
- subarachnoid hemorrhage
- artificial intelligence
- brain injury
- structure activity relationship